Literature DB >> 23856835

The prognostic role of claudins in head and neck squamous cell carcinomas.

Györgyi A Nelhűbel1, Boróka Károly, Balázs Szabó, Gábor Lotz, András Kiss, József Tóvári, István Kenessey.   

Abstract

The expression of tight junction proteins is frequently altered in epithelial cancers. The loss of cell-cell adhesion associates with enhanced metastatic potential, which underlies the role of altered expression pattern of tight junction component claudins (CLDNs). Our study assessed the expression of CLDN 1, 2, 3, 4, 7, 8 and 10 in squamous cell carcinoma of the head and neck region (HNSCC) including oropahrynx, larynx, and hypopharynx in comparison to normal epithelial tissue of the same patient. The surgical samples were examined by tissue microarray and immunohistochemistry, the expression was calculated by H-score, which took account of intensity and percentage of positivity as well. Both normal and cancerous tissue proved negative for CLDN 3, 8 and 10. Normal epithelia showed mild expression of CLDN 4, but the minimal positivity disappeared in squamous cancer. In case of CLDN 1 and CLDN 7 we demonstrated significantly increased intensity in cancer, while CLDN 2 showed decreased expression compared with normal epithelium. The normal polarity and distribution of claudins were lost in HNSCC. Moreover, preserved expression of CLDN 2 (but not that of 1 and 7) was associated with better survival, which suggested a potential prognostic role of CLDN 2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23856835     DOI: 10.1007/s12253-013-9665-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  38 in total

1.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

2.  Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer.

Authors:  F Krämer; K White; M Kubbies; K Swisshelm; B H Weber
Journal:  Hum Genet       Date:  2000-09       Impact factor: 4.132

3.  Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma.

Authors:  Gábor Sobel; Csilla Páska; István Szabó; András Kiss; Anna Kádár; Zsuzsa Schaff
Journal:  Hum Pathol       Date:  2005-02       Impact factor: 3.466

4.  Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.

Authors:  Kunio Yoshizawa; Shinichi Nozaki; Aki Kato; Mariko Hirai; Mizuki Yanase; Taisuke Yoshimoto; Iyo Kimura; Shiro Sugiura; Ayako Okamune; Hiroko Kitahara; Natsuyo Noguchi; Koroku Kato; Koichiro Ueki; Shuichi Kawashiri
Journal:  Oncol Rep       Date:  2012-11-30       Impact factor: 3.906

5.  Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.

Authors:  Patrick Michl; Claudia Barth; Malte Buchholz; Markus M Lerch; Monika Rolke; Karl-Heinz Holzmann; Andre Menke; Heiko Fensterer; Klaudia Giehl; Matthias Löhr; Gerhard Leder; Takeshi Iwamura; Guido Adler; Thomas M Gress
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 6.  Molecular targeted therapies in head and neck cancer--an update of recent developments-.

Authors:  Martin Goerner; Tanguy Y Seiwert; Holger Sudhoff
Journal:  Head Neck Oncol       Date:  2010-04-14

7.  Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma.

Authors:  Keiichi Miyamoto; Tomomi Kusumi; Fuyuki Sato; Hitoshi Kawasaki; Shigeru Shibata; Motonari Ohashi; Kenichi Hakamada; Mutsuo Sasaki; Hiroshi Kijima
Journal:  Biomed Res       Date:  2008-04       Impact factor: 1.203

Review 8.  The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.

Authors:  Michel Zimmermann; Abderrahim Zouhair; David Azria; Mahmut Ozsahin
Journal:  Radiat Oncol       Date:  2006-05-02       Impact factor: 3.481

9.  Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.

Authors:  Maliha Sadick; Stefan O Schoenberg; Karl Hoermann; Haneen Sadick
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

10.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Agnes Szik; Csilla Páska; Pál Kaposi Novák; László Szilák; András Kiss; Krisztina Bögi; Zsuzsa Schaff
Journal:  Breast Cancer Res       Date:  2005-01-31       Impact factor: 6.466

View more
  2 in total

1.  Clinical Significance of Claudin Expression in Oral Squamous Cell Carcinoma.

Authors:  Tatjana Zejc; Jörg Piontek; Jörg-Dieter Schulzke; Michael Fromm; Jürgen Ervens; Rita Rosenthal
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

Review 2.  Claudin-1, A Double-Edged Sword in Cancer.

Authors:  Ajaz A Bhat; Najeeb Syed; Lubna Therachiyil; Sabah Nisar; Sheema Hashem; Muzafar A Macha; Santosh K Yadav; Roopesh Krishnankutty; Shanmugakonar Muralitharan; Hamda Al-Naemi; Puneet Bagga; Ravinder Reddy; Punita Dhawan; Anthony Akobeng; Shahab Uddin; Michael P Frenneaux; Wael El-Rifai; Mohammad Haris
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.